
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeted Therapeutic Strategies for the Treatment of Cancer
Benjamin Victoir, Cécile Croix, Fabrice Gouilleux, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 461-461
Open Access | Times Cited: 23
Benjamin Victoir, Cécile Croix, Fabrice Gouilleux, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 461-461
Open Access | Times Cited: 23
Showing 23 citing articles:
Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy
Suling Xu, Qing-Qing Wang, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 76, pp. 12-21
Closed Access | Times Cited: 12
Suling Xu, Qing-Qing Wang, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 76, pp. 12-21
Closed Access | Times Cited: 12
Recent Advances in Metal–Organic Framework-Based Anticancer Hydrogels
Preeti Kush, Ranjit Singh, Parveen Kumar
Gels (2025) Vol. 11, Iss. 1, pp. 76-76
Open Access | Times Cited: 1
Preeti Kush, Ranjit Singh, Parveen Kumar
Gels (2025) Vol. 11, Iss. 1, pp. 76-76
Open Access | Times Cited: 1
Advances in Materials Science for Precision Melanoma Therapy: Nanotechnology-Enhanced Drug Delivery Systems
Sivakumar S. Moni, Jobran M. Moshi, Sabine Matou‐Nasri, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 296-296
Open Access | Times Cited: 1
Sivakumar S. Moni, Jobran M. Moshi, Sabine Matou‐Nasri, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 296-296
Open Access | Times Cited: 1
Exosomes derived from natural killer cells: transforming immunotherapy for aggressive breast cancer
Abdulmalik Saleh Alfawaz Altamimi, M. Arockia Babu, Muhammad Afzal, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
Abdulmalik Saleh Alfawaz Altamimi, M. Arockia Babu, Muhammad Afzal, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
The Potential of Peptide-Based Inhibitors in Disrupting Protein–Protein Interactions for Targeted Cancer Therapy
Ana Maria Sardinha Afonso, Carlos Cavaleiro, Miguel A. R. B. Castanho, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3117-3117
Open Access | Times Cited: 1
Ana Maria Sardinha Afonso, Carlos Cavaleiro, Miguel A. R. B. Castanho, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3117-3117
Open Access | Times Cited: 1
Role of Folate Receptor and CD44 in Targeting of Docetaxel and Paclitaxel Fabricated Conjugates for Efficient Cancer Therapy
Amol Tatode, Pranav Agrawal, Jayshree Taksande, et al.
Journal of Medicine Surgery and Public Health (2024), pp. 100163-100163
Open Access | Times Cited: 5
Amol Tatode, Pranav Agrawal, Jayshree Taksande, et al.
Journal of Medicine Surgery and Public Health (2024), pp. 100163-100163
Open Access | Times Cited: 5
Artemetin Inhibits Cell Growth and Activates Caspase-dependent Apoptotic Cell Death Colon Cancer HCT-116 Cells
Runsheng Chen, Lu Men
Pharmacognosy Magazine (2025)
Closed Access
Runsheng Chen, Lu Men
Pharmacognosy Magazine (2025)
Closed Access
Personalized medicine: An alternative for Cancer Treatment
Devendra Singh, Vinay Kumar Dhiman, Minakshi Pandey, et al.
Cancer Treatment and Research Communications (2024) Vol. 42, pp. 100860-100860
Open Access | Times Cited: 3
Devendra Singh, Vinay Kumar Dhiman, Minakshi Pandey, et al.
Cancer Treatment and Research Communications (2024) Vol. 42, pp. 100860-100860
Open Access | Times Cited: 3
PTT-Mediated Inhibition of Cancer Proliferation and Tumor Progression by DARPin-Coated Gold Nanoparticles
Г. М. Прошкина, Е. И. Шрамова, Ekaterina V. Serova, et al.
Journal of Nanotheranostics (2025) Vol. 6, Iss. 1, pp. 2-2
Open Access
Г. М. Прошкина, Е. И. Шрамова, Ekaterina V. Serova, et al.
Journal of Nanotheranostics (2025) Vol. 6, Iss. 1, pp. 2-2
Open Access
The effects of peptide IF7-conjugated dendrimer loaded with doxorubicin on colorectal cancer
Omid Reza Tamtaji, Mehdi Shafiee Ardestani, Abdolkarim Talebi Taheri, et al.
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Open Access
Omid Reza Tamtaji, Mehdi Shafiee Ardestani, Abdolkarim Talebi Taheri, et al.
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Open Access
Emerging targeted therapies in oral oncology: Focus on EGFR inhibition
Vishnu Priya Veeraraghavan, Shikhar Daniel, Arun Kumar Dasari, et al.
Oral Oncology Reports (2024) Vol. 11, pp. 100592-100592
Open Access | Times Cited: 3
Vishnu Priya Veeraraghavan, Shikhar Daniel, Arun Kumar Dasari, et al.
Oral Oncology Reports (2024) Vol. 11, pp. 100592-100592
Open Access | Times Cited: 3
Positive Inotropic Agents in Cancer Therapy: Exploring Potential Anti-Tumor Effects
Eduarda Ribeiro, Nuno Vale
Targets (2024) Vol. 2, Iss. 2, pp. 137-156
Open Access | Times Cited: 2
Eduarda Ribeiro, Nuno Vale
Targets (2024) Vol. 2, Iss. 2, pp. 137-156
Open Access | Times Cited: 2
Participation of TLRs in cancer immunopathogenesis and drug resistance via interacting with immunological and/or non-immunological signaling pathways as well as lncRNAs
Sharif Alhajlah
International Immunopharmacology (2024) Vol. 140, pp. 112764-112764
Closed Access | Times Cited: 2
Sharif Alhajlah
International Immunopharmacology (2024) Vol. 140, pp. 112764-112764
Closed Access | Times Cited: 2
Advances in Finite Element Analysis for Cancer Therapy Focusing on Magnetic Nanoparticle Hyperthermia
Izaz Raouf, P. Gaś, Heung Soo Kim
Multiscale Science and Engineering (2024) Vol. 6, Iss. 2-3, pp. 113-123
Closed Access | Times Cited: 2
Izaz Raouf, P. Gaś, Heung Soo Kim
Multiscale Science and Engineering (2024) Vol. 6, Iss. 2-3, pp. 113-123
Closed Access | Times Cited: 2
Unlocking the Potential of Cytarabine: A comprehensive Review from Molecular Insights to Advanced Nanoformulations and Co-Delivery Strategies for Enhanced Drug Efficacy
Salar Mohammadi Shabestari, Mehrab Pourmadadi, Hamidreza Abdouss, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 102, pp. 106346-106346
Closed Access | Times Cited: 2
Salar Mohammadi Shabestari, Mehrab Pourmadadi, Hamidreza Abdouss, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 102, pp. 106346-106346
Closed Access | Times Cited: 2
Development and optimization of multivesicular gefitinib liposomal transdermal system employing lipoid S100 for breast cancer: pharmacokinetics, bioavailability, and skin irritation studies in Wistar rats
Jayvadan K. Patel, Nulgumnalli Manjunathaiah Raghavendra, B. Sajeev Kumar
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Jayvadan K. Patel, Nulgumnalli Manjunathaiah Raghavendra, B. Sajeev Kumar
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Identifications of Similarity Metrics for Patients With Cancer: Protocol for a Scoping Review (Preprint)
Iryna Manuilova, Jan Bossenz, Annemarie Bianka Weise, et al.
(2024)
Closed Access
Iryna Manuilova, Jan Bossenz, Annemarie Bianka Weise, et al.
(2024)
Closed Access
Synthesis, Characterization and Pharmacological Screening of 1,3,4-Oxadiazoles
Ganesh Sonawane, Shweta Sharma, Ritu Gilhotra
Asian Journal of Chemistry (2024) Vol. 36, Iss. 6, pp. 1436-1446
Open Access
Ganesh Sonawane, Shweta Sharma, Ritu Gilhotra
Asian Journal of Chemistry (2024) Vol. 36, Iss. 6, pp. 1436-1446
Open Access
Host Defense Peptides: Exploiting an Innate Immune Component Against Infectious Diseases and Cancer
Taiwo Scholes Adewole, Oladiran Boniface Oladokun, Adenike Kuku
International Journal of Peptide Research and Therapeutics (2024) Vol. 30, Iss. 6
Closed Access
Taiwo Scholes Adewole, Oladiran Boniface Oladokun, Adenike Kuku
International Journal of Peptide Research and Therapeutics (2024) Vol. 30, Iss. 6
Closed Access
New Substituted Benzoxazine Derivatives as Potent Inducers of Membrane Permeability and Cell Death
Ana Conejo‐García, Yaiza Jiménez-Martínez, Rubén Cámara, et al.
(2024)
Open Access
Ana Conejo‐García, Yaiza Jiménez-Martínez, Rubén Cámara, et al.
(2024)
Open Access
Identifications of similarity metrics for cancer patients: Protocol for a Scoping Review (Preprint)
Iryna Manuilova, Jan Bossenz, Annemarie Bianka Weise, et al.
JMIR Research Protocols (2024) Vol. 13, pp. e58705-e58705
Open Access
Iryna Manuilova, Jan Bossenz, Annemarie Bianka Weise, et al.
JMIR Research Protocols (2024) Vol. 13, pp. e58705-e58705
Open Access
New substituted benzoxazine derivatives as potent inducers of membrane permeability and cell death
Ana Conejo‐García, Yaiza Jiménez-Martínez, Rubén Cámara, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 111, pp. 117849-117849
Open Access
Ana Conejo‐García, Yaiza Jiménez-Martínez, Rubén Cámara, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 111, pp. 117849-117849
Open Access
Revolutionizing Cancer Treatment: ROS-Induced Apoptosis via Nanoformulated Alkaloids
Swathi Putta, Santhosh Kumar Chinnaiyan, Rama Devi Korni, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106556-106556
Closed Access
Swathi Putta, Santhosh Kumar Chinnaiyan, Rama Devi Korni, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106556-106556
Closed Access
An Overview of the Application of Gold Nanorods in Photothermal Cancer Therapy
Maryam Deinavizadeh, Ali Reza Kiasat, Roya Mirzajani, et al.
Materials chemistry horizons. (2024) Vol. 3, Iss. 4, pp. 1-20
Open Access
Maryam Deinavizadeh, Ali Reza Kiasat, Roya Mirzajani, et al.
Materials chemistry horizons. (2024) Vol. 3, Iss. 4, pp. 1-20
Open Access